|
EXOSC2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.34336985979644E-14 |
| Normal-vs-Stage2 |
2.4147999999613E-07 |
| Normal-vs-Stage3 |
7.8159700933611E-14 |
| Normal-vs-Stage4 |
1.65645275274073E-12 |
| Stage1-vs-Stage2 |
8.158400E-01 |
| Stage1-vs-Stage3 |
1.277830E-01 |
| Stage1-vs-Stage4 |
4.214200E-02 |
| Stage2-vs-Stage3 |
5.042200E-01 |
| Stage2-vs-Stage4 |
2.526000E-01 |
| Stage3-vs-Stage4 |
4.608800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.99840144432528E-15 |
| Normal-vs-AfricanAmerican |
4.85429999996789E-06 |
| Normal-vs-Asian |
5.52779999551944E-09 |
| Caucasian-vs-AfricanAmerican |
5.759800E-01 |
| Caucasian-vs-Asian |
9.847600E-02 |
| AfricanAmerican-vs-Asian |
7.317400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.11022302462516E-16 |
| Normal-vs-Female |
1.65190083833977E-12 |
| Male-vs-Female |
3.239600E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.77724501781995E-12 |
| Normal-vs-Age(41-60Yrs) |
6.0285110237146E-14 |
| Normal-vs-Age(61-80Yrs) |
1.68387526144897E-12 |
| Normal-vs-Age(81-100Yrs) |
1.64479999953393E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.464200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.801900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.499900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.912400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.741600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.013400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.959500E-02 |
| Classical-VS-Follicular |
6.108000E-02 |
| Classical-VS-Other |
7.924800E-01 |
| Classical-VS-Normal |
1.64490643328463E-12 |
| Tall-VS-Follicular |
9.175200E-01 |
| Tall-VS-Other |
5.805400E-01 |
| Tall-VS-Normal |
1.72060032888055E-10 |
| Follicular-VS-Other |
7.001400E-01 |
| Follicular-VS-Normal |
4.11215506090912E-12 |
| Other-VS-Normal |
1.604420E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.71473946153355E-12 |
| Normal-vs-N1 |
9.65894031423886E-15 |
| N0-vs-N1 |
2.729700E-02 |
|
|
